Stryker Group President awarded 14,912 shares
Pierce James Andrew reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Pierce James Andrew reported acquisition or exercise transactions in this Form 4 filing.
Stryker Corp Group President James Andrew Pierce reported an equity award of 14,912 shares of Common Stock. The shares were granted at no cash cost upon achievement of pre-set three-year earnings per share and sales goals and will vest on March 21, 2026.
After this grant, Pierce directly holds 88,246 common shares. He also reports indirect holdings of 712 shares held by "Son GP", 713 shares held by "Son AP", and 1,595 shares held through a 401(k) account as of the same date.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 14,912 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. Acquired upon the achievement of pre-established three-year adjusted diluted net earnings per share goals and sales performance goals. The earned shares vest on March 21, 2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Stryker (SYK) executive James Andrew Pierce report on this Form 4?
Is the Stryker (SYK) Form 4 transaction a market purchase or sale?
Does the Stryker (SYK) Form 4 show any stock option exercises or sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.